Hamilton Beach Brands Holding Company (HBB)
NYSE NYSE Primary 
Hamilton Beach Brands Doesn't Deserve A Downgrade Right Now
Hamilton Beach Brands has improved revenue and profitability, aided by the HealthBeacon acquisition and favorable product mix, despite recent share price underperformance. Tariff concerns and US-China trade tensions are weighing on sentiment, but the company is actively diversifying manufacturing away from China to mitigate risk. The stock is attractively valued compared to peers, with a strong balance sheet and minimal net debt, providing resilience during near-term challenges.
Hamilton Beach Q1 Earnings Rise Y/Y, Tariffs Cloud 2025 Outlook
HBB sees improved profitability in the first quarter, driven by strong U.S. sales and premium products. Trade tensions raise concerns.
Hamilton Beach Brands Is Now Cooking
Hamilton Beach Brands has shown significant financial improvement, with revenue rising to $654.7 million in 2024 and net income increasing to $30.8 million. The acquisition of HealthBeacon has contributed positively, adding $4.3 million in sales and promising high-margin subscription revenue growth. Despite tariff risks, management is optimistic about 2025, expecting mid-single-digit revenue growth and higher operating profits due to strategic cost reductions.
Hamilton Beach Posts Y/Y Earnings Growth in Q4, Ups '25 Revenue View
HBB reports y/y revenue growth, record-high margins, and a strong cash flow in Q4, while projecting mid-single-digit revenue growth for 2025.
Hamilton Beach Brands Holding Company (HBB) Q4 2024 Earnings Call Transcript
Hamilton Beach Brands Holding Company (NYSE:HBB ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Brendan Frey - Investor Relations, ICR Scott Tidey - President & Chief Executive Officer Sally Cunningham - Senior Vice President, Chief Financial Officer & Treasurer Conference Call Participants Operator Thank you for standing by. At this time, I would like to welcome everyone to today's Hamilton Beach Brands Fourth Quarter 2024 Earnings Conference Call.
Hamilton Beach Earnings Reflect Strategic Gains But Caution Prevails
Hamilton Beach Brands Holding Company's recent dip in stock price presents a potential buying opportunity due to its strategic shift into healthcare tech and improved profit margins. Q3 2024 saw a 2% revenue increase and a 480 basis point rise in gross margins, despite higher SG&A costs. The company is expanding its product lineup and international reach, with a focus on premium markets and home healthcare.
Hamilton Beach Earnings Decline in Q3, Revenues Increase Y/Y
Higher operating expenses and significant non-cash pension termination expenses hurt HBB's earnings in Q3.
Hamilton Beach Brands Holding Company (HBB) Q3 2024 Earnings Call Transcript
Hamilton Beach Brands Holding Company (NYSE:HBB ) Q3 2024 Earnings Conference Call October 31, 2024 9:30 AM ET Company Participants Lou Nabhan - Head, IR Scott Tidey - President & CEO Greg Trepp - Former CEO Sally Cunningham - SVP, CFO & Treasurer Conference Call Participants Adam Bradley - AJB Capital Operator Thank you for standing by. My name is Ian, and I will be your conference operator.
Hamilton Beach Brands Holding Company (HBB) Q2 2024 Earnings Call Transcript
Hamilton Beach Brands Holding Company. (NYSE:HBB ) Q2 2024 Earnings Conference Call August 1, 2024 9:30 AM ET Company Participants Lou Nabhan - Head of Investor Relations Gregory Trepp - President & Chief Executive Officer Scott Tidey - President Sally Cunningham - Senior Vice President, Chief Financial Officer & Treasurer Conference Call Participants Operator Thank you for standing by.
Hamilton Beach (HBB) Q2 Earnings Rise Y/Y, 2024 View Robust
Higher sales volumes and a favorable product mix aid Hamilton Beach's (HBB) earnings in Q2.
Zacks Initiates Coverage of Hamilton Beach With Neutral Recommendation
Discover why Zacks rates Hamilton Beach (HBB) as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore how HBB emphasizes its robust market positioning and strategic foray into the health tech sector, showcasing improved financials while acknowledging potential risks.
